eTable 1. Estimation of race-and gender-specific ASCVD risk using the ASCVD Pooled Cohort risk equations 1 Equations parameters* S 0 (t) at 5 years † S 0 (t) at 10 years .001 N<11 indicates fewer than 11 participants are used in calculating the statistic. These numbers are suppressed per data use agreement with Centers for Medicaid and Medicare Services. Other cells are not presented to prevent calculating actual number in the suppressed cells. ASCVD: atherosclerotic cardiovascular disease; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; REGARDS: REasons for Geographic And Racial Differences in Stroke; SBP: systolic blood pressure; SD: standard deviation; TC: total cholesterol. † Non-HDL cholesterol between 100 and 219 for the 1,255 who had not fasted prior to their REGARDS study visit. eFigure. Inclusion criteria applied to the REasons for Geographic and Racial Differences in Stroke (REGARDS) study for the validation of the Pooled Cohort risk equations † Heart failure was defined by use of digoxin assessed by pill bottle review during the REGARDS in-home study visit. ‡ Non-HDL cholesterol between 100 and 219 mg/dL was required for the 1,255 participants who did not have a valid LDL-C measurement (i.e., were not fasting prior to their REGARDS study visit or had serum triglycerides > 400 mg/dL).HDL: high density lipoprotein; LDL-C: low density lipoprotein cholesterol.
